D. Gorecka (Warsaw, Poland), O. C. Burghuber (Vienna, Austria)
Complexity of the relationship between cardiovascular co-morbidity, multi-dimensional assessment and mortality in a primary care cohort with COPD
N. Keaney, A. Kay, T. Hildreth, I. Taylor (Sunderland, United Kingdom)
|   |
Right and left ventricular dysfunction in patients with COPD and heart failure
N. Karoli, A. Rebrov (Saratov, Russian Federation)
| |
Impact of cardiovascular comorbidities on COPD exacerbations
S. Antoniu, C. I. Andrei, R. Iulia (Iasi, Romania)
| |
Arterial stiffness in COPD patients is associated with hypoxemia and plasma nitric oxide level
T. Brodskaya, V. Nevzorova, B. Geltser, E. Motkina (Vladivostok, Russian Federation)
| |
Heart rate variability, nocturnal hypoxemia and C-reactive protein in patients with chronic obstructive pulmonary disease (COPD)
R. Inchingolo, G. Corbo, G. Sgueglia, A. Gaballo, L. Paladini, G. Lanza, S. Valente (Rome, Italy)
| |
Ischemic heart disease in patients with COPD
N. Karoli, A. Rebrov (Saratov, Russian Federation)
| |
Impulse oscillometry in patients with acute exacerbation COPD and severe chronic heart failure
D. Koruga, C. Borislav, N. Agbaba, G. Plavec (Novi Sad, Belgrade, Serbia And Montenegro)
| |
proBNP is not elevated in patients with advanced COPD and normal left cardiac function
M. B. Lund, O. Bjørtuft (Oslo, Norway)
| |
Relation of PRO-BNP values with right ventricular dysfunction in respiratory insufficiency patients with COPD
E. C. Seyhan, S. Altin, E. Cetinkaya, S. N. Sokucu, L. Karasulu, A. Gencoglu, N. Simsek (Istanbul, Turkey)
| |
24-h Holter monitoring in COPD. Correlations with clinical type, severity of disease and comorbidities
L. Ciobanu, D. Turcanu, L. Livint (Iasi, Romania)
| |
Inflammatory pathways in patients with chronic obstructive pulmonary disease and paroxysmal atrial fibrillation
I. Burazor, M. Krstic (Nis, Serbia And Montenegro)
| |
Changes of systemic vessels mechanical properties in COPD
V. Nevzorova, T. Brodskaya, B. Geltser (Vladivostok, Russian Federation)
| |
Impact of the body mass index on the FEV1 value and its mean yearly decline in COPD patients
P. Pavlov, Y. Ivanov, P. Glogovska, T. Popova, A. Velkova, V. Nozharov (Pleven, Bulgaria)
| |
Fat free mass and exacerbation of chronic obstructive pulmonary disease
R. Baghai-Ravary, J. Quint, G. Donaldson, J. Wedzicha (London, United Kingdom)
| |
Determinants of 6-months mortality in elderly patients admitted for non-acidotic acute exacerbation of COPD (AECOPD)
P. Ranieri, A. Bianchetti, A. Margiotta, A. Virgilio, M. Trabucchi, E. M. Clini (Brescia, Modena, Italy)
| |
A comparison of bone mineral density in elderly patients with COPD and bronchial asthma
H. Mahmoud, M. Alm-eldien (Sohag, Egypt)
| |
Anaemia in COPD: mortality and disease severity
F. Brims, A. Asiimwe, A. Chauhan (Porstmouth, Hampshire, Portsmouth, Hampshire, United Kingdom)
| |
Non-respiratory events in patients with stable COPD
C. Santiveri, A. Marin, E. Miguel (Barcelona, Spain)
| |
Coexisting chronic diseases in COPD – cause of elevated level of C-reactive protein?
B. Kuznar-Kaminska, J. Kaminski, B. Brajer, H. Batura-Gabryel (Poznan, Poland)
| |
Diabetic polyneuropathy is associated with respiratory muscle weakness in type 2 diabetes
H. J. Kabitz, F. Sonntag, D. Walker, A. Schwoerer, S. Walterspacher, S. Kaufmann, F. Beuschlein, J. Seufert, W. Windisch (Freiburg, Munich, Germany)
| |